June 4 - 5, 2025
Javits Convention Center
Peter Tadlock, NY 2016

NYS Cannabis Business Licensing News & More

“We decided to exhibit here because

we’re excited about

 the New York market,

the New Jersey market…”

Michael Williamson, PIPP Horticulture,
exhibiting at CWCBExpo NY 2023

Get Prime Exhibit Space Today

Michael Williamson, Director of Cultivation, PIPP Horticulture
Michael Williamson, Director of Cultivation, PIPP Horticulture
New York State News

NYS Licensing News

The Office of Cannabis Management and the Cannabis Control Board regulators voted on November 27 to settle the two lawsuits that held up hundreds of Cannabis Adult Use Retail Dispensary (CAURD) card holders from actually opening up their dispensaries. The temporary injunction put forth was lifted for the two lawsuits and gave the green light to the 436 licensees to finally move forward. At least 23 of those CAURD holders were ready months ago before the injunction and can now proceed.

Governor Kathy Hochul expressed that NYS is committed to supporting legal cannabis shops and shutting down illegal cannabis operations.

Governor Hochul Announces New Dispensary Openings

The submission date deadline for NYS Licensing was December 18, 2023. Governor Kathy Hochul and the Cannabis Control Board are already looking ahead with enthusiasm as NYS seeks to expand its legal cannabis marketplace as new retail shops open up. Read what they had to say on December 14 about the anticipated new dispensary openings happening now and into 2024.

Seal of Governor Kathy Hochul

First Dispensary Opened in Mt. Vernon, Westchester

Congratulations to Elevate Cannabis, the new and first legal recreational use dispensary to open up in Westchester County in Mount Vernon, New York. The dispensary opened its doors in early December and offers delivery services as well as in-store cannabis retail experiences. Elevate Cannabis is mission-oriented and is supportive of social equity causes, healing and related quality of life issues.

New Jersey News

NJCRC Announces Reduced Fees

The New Jersey Cannabis Regulatory Commission (NJCRC) announced some good news for medical cannabis patients and their caregivers. Instead of the $50 per year for most registrants and the $20 for seniors to register in the Medicinal Cannabis Program (MCP), it is now $10 for everyone as of December 7, 2023. Plus, patients and caregivers will be able to receive free Digital ID cards or pay $10 for a physical card.

NJ Cannabis Regulatory Commission

More NJ Licenses Announced

The NJCRC announced dozens of new licenses being issued to applicants.

Putting cannabis business to good use and making a difference

NJ Governor Jim Murphy and Attorney General Matthew Platkin announced anti-violence measures that will be funded with $15MM, of which $5MM is coming from marijuana revenue. The program is being funded by the Fiscal Year 2024 Appropriations Act and includes $5 million from the Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Fund.

NJ Attorney General
Federal News

POTUS and Cannabis

President Joe Biden issued a Proclamation on December 22nd for those individuals with certain federal level marijuana convictions. “I am issuing a Proclamation that will pardon additional offenses of simple possession and use of marijuana under federal and D.C. law,” the President stated. This recent action expands the pardons that President Biden had made previously.

International News

Germany’s Cannabis Legalization Delayed

Germany was set to legalize cannabis starting as soon as the new year but has been delayed until well into 2024 according to the German Health Minister, Karl Lauterbach. Germany appears to have a well-thought out and well debated cannabis legalization plan that includes cannabis social clubs and modifications to home grow regulations.

Ukraine’s Cannabis Bill Expected to Pass Early 2024

In our July Newsletter we highlighted that Ukraine’s President Volodymyr Zelensky is in favor of legalizing medical marijuana, and that the country’s legislature was poised to do so until an opposition faction blocked its passage. It is expected that this opposition will be overcome and the bill will pass in January 2024, and the law will become effective six months later.

“The bill, which initially listed cancer and war-borne PTSD as eligible conditions, moves marijuana from strictly prohibited to available for medical use with a prescription under List II of the country’s drug code.”

my cannabis
SPECIAL FEATURE: Interview with Ken R. Weinberg, MD (Part 2)

We are excited to share Part 2 of our “Cannabis as Medicine” interview with Ken R. Weinberg, MD, Chief Medical Officer and Founder of Cannabis Doctors of NY.

This month our discussion focuses on the medical marijuana market and medical marijuana patients and how adult-use legalization is affecting medical use.

Ken Weinberg, MD

Ken is a practicing physician with decades of experience in emergency medicine and urgent care. He is a published author of medical articles across many disciplines and is currently working on a book about his experiences in front-line medicine, including the 1500 or so patients he has seen as a registered Cannabis Practitioner since 2016. He is the Founder of Cannabis Doctors of New York.

Among his many medical commitments, he serves as the Attending Cannabis Consultant at Inspir – a private nursing home in New York City. At that facility he provides medical expertise and guidance for elders who are interested in using cannabis as part of their medical care. Ken works with several dispensaries in the New York area as well.

INTERVIEW, PART 2: CANNABIS AS MEDICINE

CWCBExpo – Recently, the New York State Cannabis Control Board approved six of the state’s Registered Operators (ROs)* to participate in the adult-use market. What do you think about this and how do you think it will affect the medical cannabis marijuana market for patients and appropriate patient care? Will it help? Are you concerned for patient care and are you concerned that new users who would have otherwise consulted with a medical practitioner will now not be getting the optimal medical advice?

Dr. Ken Weinberg
Dr. Ken Weinberg
Cannabis Doctors of New York
Cannabis Doctors of New York

Ken – I have mixed feelings. The fact that many of our medical patients are opting to go to the rec market has caused a precipitous drop in medical patients. And while I am sure that some of the people who have made the switch will do okay, one of the reasons I like the NY medical cannabis space is that there are pharmacists involved. Cannabis medicine is medicine, with exact dosing, possible drug interactions and effects that budtenders should not be opining on.

*Editor’s Note: Medical dispensaries (ROs) must have a registered pharmacist to dispense the medical marijuana to patients. There is also a requirement that any RO who is approved for participation in the adult-use market must have a separation of the medical marijuana and the adult-use retail sections.

CWCBExpo – Describe your recent presentation to a Northwell Resident group regarding educating them on cannabis as a medical treatment. Were there any particular conditions, diseases or symptoms that you focused on in the presentation? What was the reaction of the medical residents who attended the presentation – was it well received?

Ken – For the last three years, I’ve been giving this lecture to the Family Practice residents. I talked about the Endocannabinoid System and similarities of the plant cannabinoids to the endogenous (produced inside the body) cannabinoids.

I spoke about how well my patients with autoimmune diseases (like Inflammatory Bowel Disease) do and about how I am seeing how very beneficial cannabis can be for patients with dementia. This was the best received talk I’ve given and I suspect I left them (and an initially skeptical Attending Physician) wanting more.

“I love my involvement in cannabis medicine because it provokes me all the time, and challenges me to understand how we interact with the plant, and how it may well be involved (in the best way) with the placebo effect…”

CWCBExpo – What do you think about Psychedelics as treatment for many medical conditions? Where do you see this going?

Ken – I think this is a huge, burgeoning area of medicine with great potential for benefits. Unfortunately, as with so much else in this country, the fact that they remain Schedule 1 narcotics leads to a hodgepodge of regulations and research in various states, and the federal government unable to provide some uniformity of guidance.

CWCBExpoWhat about micro dosing and the use of psychedelics as a medicine for treatment?

Ken – Micro dosing can be a good way to start, especially for “cannabis-naive” patients and the elderly, who may be very sensitive to the effects. I’m not involved with psychedelics but they seem to be very promising for a variety of conditions.

CWCBExpo What excites you most about practicing medicine and devoting your life to it? And furthermore, what can explain the motivation for you to include cannabis as a medical treatment?

Ken – I am a third-generation MD, and one of three brothers. One brother was a Family Practice and Naturopathic physician, the other an Oriental Medicine and acupuncturist so it feels like it’s in the blood. In fact, my niece is an OB-GYN doc, making her the fourth generation of Drs. Weinberg.

I think that medicine is a field where you can continue to grow, enrich your understanding, and be stimulated intellectually as well as be emotionally gratified even as you advance in age. I love my involvement in cannabis medicine because it provokes me all the time, and challenges me to understand how we interact with the plant, and how it may well be involved (in the best way) with the placebo effect. Lastly, as you alluded to, my love and long involvement with the interface of literature and medicine has caused me to write stories of my patient encounters for many years and has now led to my writing a book incorporating those stories along with the many influences on my life as a political activist doctor and writer.

We featured Part 1 of this interview with Ken in our August 2023 Newsletter.
In case you missed it, click here to read it now.

THIS MONTH’S ARCHIVED VIDEO

“CannaVest East: Exploiting Ground Floor Valuations – Family Office Cannabis Investing 101”

We are showcasing our consumer products session from the CWCBExpo conference program at the Javits Center on June 2, 2023. This session discusses the current cannabis investment environment.

Moderated by Steven Saltzstein, FORCE Family Office; with Adam Rosenberg, President, Vlasic Bioscience; Brett Finkelstein, Founder, Phyto Partners; David Engel, CEO, President, Full Moon Real Estate Investments and Full Moon Investments.

CWCBExpo conference session, "Ground Floor Valuations" June 2, 2023

(From the left) David Engel, Steven Saltzstein, Adam Rosenberg and Brett Finkelstein.

The CWCBExpo BLOG

CWCBExpo blogs contain relevant, timely information. Recent subjects include dispensaries, and lawmakers’ pushes for reform.

A shopper stands at checkout making a purchase at a cannabis dispensary.
The CWCBExpo Speaker Proposal Deadline Fast Approaching!
The deadline is January 15, 2024.

Apply to speak today.

Happy New Year to All!

CWCBExpo, 11th Annual

June 5 – 6, 2024
Javits Convention Center, NYC

Industry Yacht Party, Liberty Island, 2022

NY and NJ Markets Continue to Expand 

Each month, Cannabis World Congress & Business Exposition (CWCBExpo) offers a convenient roundup of the biggest cannabis news stories and hemp headlines emerging across the nation. Get these updates in your inbox by subscribing to our email newsletter, or follow us on Instagram, LinkedIn, Facebook, or Twitter (now X) to get the most recent edition when it’s published.

Step into the final stretch of 2023 with our December regional cannabis news update. The edition spotlights a game-changing decision by New York’s Cannabis Control Board, as well as the flourishing market in New Jersey. As we close out the year, witness the expansion of markets across the Northeast as we unpack the details of some of the most pivotal moves in our area. 

MSOs approved to enter the New York adult use market

Following the state’s Supreme Court decision on December 1st to lift an injunction hindering the issuance of new Conditional Adult-Use Retail (CAURD) Licenses, the Cannabis Control Board (CCB) in New York has officially given the green light to multistate operators (MSOs) with medical marijuana licenses to enter the adult use market on December 29th, 2023. 

The decision comes exactly one year after the state launched recreational sales. Thus far, the CCB approved the following six organizations to join the adult use market: 

  • Columbia Care NY, whose parent is New York-based MSO The Cannabist Co.
  • Curaleaf NY, part of New York-headquartered MSO Curaleaf Holdings
  • Etain, owned by RIV Capital, a Toronto-based investment firm
  • NYCanna, part of New York-headquartered MSO Acreage Holdings
  • PharmaCann of New York, whose parent is Chicago-based MSO PharmaCann
  • Valley Agriceuticals, whose parent is Chicago-headquartered MSO Cresco Labs

While the waiting period had been adopted to provide a first-to-market advantage to social equity retailers and smaller supplies, gears have shifted in an effort to expand retail options as hundreds of unlicensed shops continue to plague the market. 

These six companies will eventually be permitted to set up co-located adult-use sales at up to three of their existing medical dispensaries. For the time being, however, each was approved for a single shop that can open by the end of the month. The CCB also approved new medical-only locations for both Citiva and Fiorello. 

New Jersey sales increase as prices drop 

New Jersey cannabis sales are stacking up high, as the recreational market recorded $206.1 million for Q3 2023. This brings the state’s total legal market revenue for the year to $762.9 million. The New Jersey Cannabis Regulatory Commission (CRC) reported a 10% increase in sales in the same quarter, from the $160.2 million in adult use cannabis revenue generated from April through June. 

According to CRC Executive Jeff Brown, consumers are attracted to the licensed marketplace, which includes 70-plus adult-use dispensaries statewide. As a result, prices for products are starting to come down. The average flower price dropped to roughly $354 per ounce at adult-use retail, representing a 10.5% decrease from January’s average price of $396. 

“New Jersey’s market continues to grow,” Brown said during the commission’s regular meeting on Dec. 7th. “For the first time in history, legal cannabis sales in New Jersey eclipsed $200 million in the third quarter of 2023. That includes just shy of $177 million of adult-use sales and just shy of $30 million of medicinal sales.”

New Jersey’s adult-use sales accounted for nearly 86% of all sales for the third quarter of 2023. The state’s medical market continues to shrink due to expanded opportunities for consumers.

More dispensaries are opening across New York 

Gov. Kathy Hochul (D-NY) has announced the opening of one dozen new adult-use dispensaries from Brooklyn to Buffalo. By the end of December 2023, the state anticipates having at least 37 adult-use dispensaries open for businesses. Among the opening locations, eight are majority Black-owned, five are Hispanic-owned, and nine are woman-owned.

“As New York expands the most equitable cannabis market in the nation, my administration remains committed to building a safe industry for all New Yorkers that will grow our small business community,” Governor Hochul said in a press release. “These new dispensaries continue our mission of strengthening our legal market while at the same time helping to push out the bad actors who skirt our laws and undermine all we are trying to accomplish.”

Below is a list of the dispensaries that have recently opened or are set to open this month. Opening dates are subject to change: 

  • Hush – 2460 Williamsbridge Road Fl 1, Bronx 10469, (Opened on Thursday, Dec. 14, 2023)

  • Grow Together – 2370 Coney Island Ave., Brooklyn 11223, (Opened Tuesday, Dec. 19, 2023)

  • Dagmar Cannabis – 412 W Broadway, New York 10012, (Opening on Friday, Dec. 15, 2023)

  • THC Herbal Care – 1412 Lexington Ave., New York 10128 (Tentative opening, Jan. 4, 2024)

  • Happy Days – 105 Route 109, Farmingdale 11735 (Tentative opening on Saturday, Dec. 23, 2023)

  • Elevate – 127 S Terrace Ave., Mount Vernon 10550 (Opened on Monday, Dec. 11, 2023)

  • The Highest Peak – Village of Potsdam, 5 Market St., Potsdam 13676 (Opened on Thursday, Dec. 7, 2023)

  • The Firehaus – 7479 US Highway 11, Potsdam 13676 (Opened Wednesday, Dec. 13, 2023)

  • 420 Bliss – 740 Hoosick St., Brunswick 12180 (Opened on Thursday, Dec. 7, 2023)

  • Capital District Wellness – 997 Central Ave. Suite 200, Albany 12205 (Opened on Friday, Dec. 8, 2023)

  • Amsterdam Cannabis – 1451 State Highway 5S, Amsterdam 12010 (Opened on Friday, Dec. 9, 2023)

  • Premier Earth Corp – 1297 Hertel Ave., Buffalo 14216 (Opened on Wednesday, Dec. 13, 2023)

  • MJ Dispensary – 900 Jefferson Rd Ste 902, Rochester 14623 (Opened on Tuesday, Dec. 12, 2023)

Embrace growth with CWCBExpo

December marks a transformative period for the Northeast’s cannabis landscape. As we bid farewell to 2023, the region is poised for continued growth and innovation. Stay up to date with our latest updates and join us for insightful discussion at our upcoming in-person conferences – where the pulse of the industry will continue to beat strong in the new year.  

Cannabis Flower Market: By The Numbers

Cannabis flower has become the top seller in the cannabis industry in legal markets throughout the U.S. Although the term “cannabis” has evolved to include a wide selection of products, flower has proven to have immense staying power. Whether purchasing flower in bulk or in ready-to-smoke pre-rolls, flower is a top product for consumers.

Cannabis flower: King of the industry

The dried, cured, and ready-to-use buds of the cannabis plant dominate the U.S. cannabis market, leading the way in sales volume in most legal markets.

According to Statista, U.S. cannabis flower sales are projected to grow to more than $15 billion by 2025, more than double the $7.2 billion flower sales grossed in 2021. (This figure is separate from cannabis pre-rolls, a category that achieved $1.5 billion in sales in 2022 on its own.) Data from cannabis analytics company Headset paints a similar picture of rapid growth, from $2.36 billion in sales in 2018 to $4.83 billion through October 2022.

At the same time, flower’s market share is declining as a wider variety of cannabis products, like edibles and concentrates, gain popularity among consumers. Headset reported a five point decline in flower’s market share from 2018 to 2022, from 45.7 percent to 40.7 percent. And yet, it remains the most popular cannabis product by far. Headset also reported that, as of 2022, edibles accounted for 11.8 percent of total U.S. cannabis sales. The third-largest category, concentrates, accounted for 8.3 percent.

Factors influencing the cannabis flower market

There are many factors influencing the growth of the cannabis flower market in the U.S., ranging from an expanding variety of cannabis products from breeders, to the launch of new legal markets, to price compression in maturing legal markets. Here’s a closer look at each of these factors and how they may impact cannabis flower sales in the coming years.

Cannabis product diversity

As the cannabis industry matures, a wider variety of product types are reaching dispensary shelves including concentrates, edibles, either, vape cartridges, tinctures, and topicals. Although cannabis flower remains the most popular among consumers in the U.S., these other product types offer alternatives. And as consumers in more markets become familiar with them, they’re increasingly choosing them in addition to flower.

Consumption product trends point to increased sales across flower and these other categories. The introduction of edibles, concentrates, topicals, and tinctures don’t preclude increasing sales of flower, as the data above shows. Expect consumers to continue to purchase flower even as they decide to incorporate other cannabis products into their routines.

New legal markets

Although flower’s market share may decline as new product types catch on, projections suggest that sales will increase. That’s especially true as new legal markets come online. For example, New York’s adult use cannabis market formally opened its doors in December 2022 and started seeing retail shops open in 2023. Grandview Research estimates that the New York adult use cannabis market alone will be worth more than $7 billion by 2025.

And that’s just one new legal market. New Jersey also recently began adult use cannabis sales in April 2022 and the market is similarly poised for growth. From April to December, adult use consumers in the state purchased $329 million worth of cannabis, and the market is estimated to be worth between $1.8 billion and $3 billion already.

As more states consider legalizing cannabis, the value of the U.S. market is only likely to increase. And, since cannabis flower typically holds a significant plurality of the market share in legal states, expect flower sales to increase as well.

Price compression

In many states, the price of cannabis flower is dropping, making it a more cost-effective option for consumers and contributing to profit margins for dispensaries. However, this also means the volume dispensaries need to sell to generate significant revenue has increased.

The average price per gram of flower fell across multiple state markets from 2020 through 2022, including in California, Colorado, and Michigan. Price compression occurs at varying rates in each state market based on supply and demand, and it’s especially volatile since each state must legally have self-contained supply chains.

In Michigan, for example, price compression was most dramatic during this period, with the price of flower falling from just under $14 per gram to nearly $4 per gram, according to Headset data. In California, the decline was less dramatic, with the price dipping from around $9 per gram to about $7 per gram.

Cannabis flower competitive landscape

The competitive landscape around cannabis flower is fragmented, including multi-state operators (MSO) with vertically integrated businesses that include cultivation as well as small, independent cultivators. These are examples of some of the biggest cannabis cultivators in North America, each with more than 1 million square feet of growing space.

  • Ultra Health: Based in New Mexico, Ultra Health has 9,213,000 sq. ft. of space dedicated to cannabis production, including greenhouses, warehouses, and outdoors growing space.
  • Mammoth Farms: Located in Colorado, Mammoth farms brings 3,484,800 sq. ft. of cannabis production to the U.S., including its greenhouses, outdoor grow, and warehouses. 
  • Hexo Corp: Hexo Corp is a Canadian cannabis producer, responsible for a 2 million sq. ft. greenhouse operation in Quebec. 
  • Copperstate Farms: Named after Arizona’s state nickname, Copperstate Farms maintains 1.7 million sq. ft. of greenhouses dedicated to the production of cannabis flower. 
  • Los Suenos Farms: The Colorado-based Los Suenos Farms operates 1,428,000 sq. ft. of both outdoor grow space and greenhouses. 
  • Canna Hub: Located in California, Canna Hub’s facilities total 1.2 million sq. ft. of greenhouses and warehousing space. 
  • Village Farms: Village Farms operates out of Canada and has 1.1 million sq. ft. of greenhouse space in British Columbia.

There are many other cultivators, of course, including small scale grows that serve their local markets. In many states, home grow is also legal, allowing consumers to grow their own plants for personal consumption. It’s also worth noting that not all of the cannabis cultivated by the producers above is sold as flower — much of it is used in manufacturing extracts to be sold as concentrates or used as ingredients in infused cannabis products.

Cannabis flower never goes out of style

Despite rampant innovation and consumers’ increasing familiarity with new types of cannabis products, cannabis flower remains a favorite. Expect flower to lead the way as the cannabis industry grows in the coming years. At the center of all the exciting new cannabis products and legal markets coming online is the plant itself, and flower offers consumers one of the closest connections that the plant has.

September 2023 National News Update: Unveiling Key Cannabis Bills in Congress 

Each month, Cannabis World Congress & Business Exposition (CWCBExpo) offers a convenient roundup of the biggest cannabis news stories and hemp headlines emerging across the nation. Get these updates in your inbox by subscribing to our email newsletter, or follow us on Instagram, LinkedIn, Facebook, or Twitter (now X) to get the most recent edition when it’s published.

 

 

As September 2023 comes to a close, the U.S. Congress once again jumps into the ongoing narrative of cannabis reform. From bipartisan efforts to advance banking bills to moves to federally legalize cannabis, the House of Representatives is at the forefront of these transformative discussions. Join us as we unpack the latest developments in cannabis legislation and defining moments of September. 

 

SAFER Banking Act clears committee

 

 

 

This story was edited on Sept. 27th, 2023 to include an update on the SAFER Banking Act.

In a milestone that has sent waves of excitement throughout the cannabis industry, the bipartisan Secure and Fair Enforcement Regulation (SAFER) Banking Act has made its way through committee.

 

On Sept. 27th, the Senate Banking Committee voted to approve the SAFER Banking Act, advancing this legislation to the Senate floor. While additional amendments are pending, the 14-9 vote of approval from the committee is breathing new life into a bill that has stalled for years.

 

U.S. Senators Jacky Rosen (D-NV) and Steve Daines (R-MT) introduced the SAFER Banking Act on September 20th, just ahead of a pivotal committee vote. The bill, formerly known as the SAFE Banking Act, aims to ensure that legal cannabis businesses can reliably access banking and insurance services, ultimately fostering safe communities and broadening economic opportunities.

 

Currently, federal regulations strictly control financial services for cannabis companies, resulting in a lack of access to crucial banking for many independent operators. Consequently, numerous businesses operate predominantly with cash, leaving operators, customers, and staff at increased risk of criminal activity. 

 

“This legislation will help make our communities and small businesses safer by giving legal cannabis businesses access to traditional financial institutions, including bank accounts and small business loans,” the senators said. “It also prevents federal bank regulators from ordering a bank or credit union to close an account based on reputational risk.”

 

In a separate statement, Senate Majority Leader Chuck Schumer (D-NY) said that he is committing to attaching legislation incentivizing state-level cannabis expungements and restoring gun rights for medical cannabis patients. Specifically, he said he would move to add the Harnessing Opportunities by Pursuing Expungement (HOPE) Act and Gun Rights and Marijuana (GRAM) Act to the final legislation.


House Democrats introduce bill to federally legalize cannabis

 

 

 

Representative Jerrold Nadler (D-NY) has rekindled efforts to federally legalize and regulate cannabis. On September 20th, Nadler reintroduced the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act, a comprehensive bill that not only seeks to dismantle the federal prohibition of cannabis but also includes provisions for taxing and expunging prior convictions related to the plant. The bill has 33 co-sponsors, all of whom are Democrats. 

 

This marks the third time the MORE Act has made its way to the House, with prior versions passing. However, its reintroduction under Republican control raises questions about its potential progression.

If passed, the MORE Act would deschedule cannabis, removing it from federal drug restrictions while allowing states to retain regulatory authority over its legality. However, it would not require states to legalize cannabis. It also proposes a federal tax structure for cannabis sales, starting at 5% for the first two years and rising to 8% percent by the fifth year. A portion of the tax revenue would be aimed at addressing the impact of federal prohibition, particularly on communities of color. 

 

Congressional committee approves CURE Act, removing cannabis as a barrier to federal employment

 

 

 

The House Oversight and Accountability Committee officially passed the Cannabis Users’ Restoration of Eligibility (CURE) Act on Sept. 20th with a 30-14 vote. Sponsored by Reps. Jamie Raskin (D-MD), Nancy Mace (R-SC), and Earl Blumenauer (D-OR), the bill aims to eliminate barriers to federal employment and security clearance based on past cannabis consumption. The CURE Act would also allow those previously denied a security clearance or a federal job opportunity based on cannabis use a chance to have the denial reviewed. Supporters of the bill included 30 House members, 10 of which are Republican. 

 

However, while initially designed to cover both past and current cannabis consumers, members adopted amendments from James Corner (R-KY) to refine specific provisions. The amended bill narrows the protections to apply exclusively to prior cannabis use. This means federal workers and security clearances could still face penalties for active consumption. Additionally, the amendment addresses language concerning agencies’ obligation to review denials based solely on cannabis use for security clearances or employment. 

 

“Federal hiring policies are confusing enough, and this is one area where we can work in a bipartisan way to clarify and codify what is largely an existing practice,” Chairman Corner said during the full committee meeting on Sept. 20th.

 

Join the conversation with CWCBExpo


The bills introduced this month are poised to shape the future of cannabis policy in the United States. Those eager to stay at the forefront of this evolving landscape must look no further than CWCBExpo. Our comprehensive coverage and
annual B2B conference offer accurate updates and the opportunity to connect and network with experienced industry professionals. With CWCBExpo, you’re not just staying informed but becoming part of the conversation. 

A conference attendee in a brown jacket stands among a crowd to address a speaker during a session at CWCBExpo.

What You’ll Learn At A Cannabis Trade Show

Cannabis trade shows offer a great opportunity for industry professionals and entrepreneurs to network, learn, and showcase their products and services. Whether you’re a seasoned member of the industry or just beginning your journey, cannabis trade shows serve as a goldmine of knowledge and networking opportunities. In this blog, we’ll explore what you can expect to learn. 

What you’ll learn at a cannabis trade show 

From groundbreaking new products to regulatory compliance updates, B2B trade shows provide the insight and opportunities necessary to succeed in the cannabis industry. If you want to stay on top of industry trends and network with some of the leading professionals and brands in the space, these conferences are the place to be. Here’s some of what you can expect to learn when you attend a cannabis trade show.

Industry trends and insights 

The cannabis industry is always evolving, so staying on top of trends — from what customers are most interested in buying to the most effective brand strategies — is an important part of retaining a competitive edge. Cannabis trade shows provide expert panels and Q&As that can help you stay up to date on recent developments in the industry, providing actionable insights that you can immediately implement for your business. 

When attending panels and speaking sessions at a cannabis trade show, expect to learn about the market and size of the cannabis industry. You’ll also learn the latest regulatory developments in your market, the hottest products that consumers are looking for, and how to build successful partnerships with other companies.

Product knowledge 

The best cannabis trade shows are home to a wide range of businesses hailing from every market segment in the industry, including those with the most popular consumer products of the day. Take the opportunity to connect with these B2C exhibitors and learn about their products and how the market is reacting to them. You may even have the opportunity to observe some product demos, giving you the chance to see firsthand just what makes these products so special. 

Cannabis trade show floors are replete with new product innovations, from vaporizers and extracts to infused cannabis beverages. To understand the industry, you need to know what products consumers are buying, and a trade show can be a great way to see some of the latest and greatest consumer products out there. 

Regulatory compliance and legal issues 

Regulatory compliance and legal issues are critical concerns for businesses in the cannabis industry, where the rules are constantly changing as states work to set up their legal markets. Cannabis trade shows often showcase exhibitors and host sessions that focus on licensing, testing, and other regulatory requirements. Trade shows like CWCBExpo also offer education sessions led by industry experts to provide attendees with information on regulatory and compliance requirements to help navigate the complex legal landscape of the cannabis industry. 

Marketing and branding 

Top quality cannabis marketing firms are bound to attend cannabis trade shows, making these expositions a great opportunity to meet your next marketing team. Seminars and workshops focused on marketing and branding are often led by experts in the field, giving you the insights you need to effectively build your brand and spread the word to your target audience. 

If you want to take your business to the next level, you could partner with these companies to get professional marketers in your corner and start reaching your customers in new and creative ways. Branding and marketing is essential to standing out in a crowded market, and trade shows are a great place to start.

Cultivation and extraction

Cannabis trade shows also bring together plant-touching experts in cultivation and manufacturing, the critical players who underpin the entire supply chain of the cannabis industry. By attending a cannabis trade show, you’ll likely gain knowledge on topics ranging from pest management to sustainable growing practices. If you’re a retailer, you can use this opportunity to connect with potential suppliers and find top quality flower and extracts. After all, there wouldn’t be a cannabis industry without the cultivators who grow the flower and the manufacturers that process it into a wide variety of consumer products.

5 tips to get the most out of trade show educational seminars   

Each CWCBExpo conference offers cutting-edge seminars and educational sessions to provide direct industry insight and knowledge to attendees. These sessions are designed to provide attendees with valuable information regarding the latest trends, emerging technologies, and the best business practices for success. To make the most out of the trade show’s education sessions, attendees should follow a few key tips. 

1. Plan ahead

Looking at the agenda helps you get the most out of the education sessions at cannabis trade shows. With so many speakers and seminars to choose from, it can be overwhelming to navigate the schedule. Research and identify the topics you’re most interested in so you can create a game plan and prioritize sessions based on your interest. Not every panel will apply to your business, so use those times to walk the show floor and meet exhibitors. On each day of a cannabis trade show, there’s likely a speaking session that will apply to your business so come each day with an itinerary to get the most out of your visit.

2. Take notes

Bring a notepad and pen or pencil to every session you attend so you can take detailed notes to analyze after the trade show. Many of these sessions will include comments from industry leaders that you can use to boost your own business, and you never know when the next helpful tidbit of information might be shared. So pay close attention and jot down any good ideas you hear, as well as your thoughts on how they might apply to your business. 

Forgot your journal and pen? Not to worry — you’ll likely be able to pick them up as giveaways from exhibitor booths on the floor. And you can always use a note-taking app on your phone to record the advice you get from each session.

3. Engage with speakers 

Take the opportunity to ask relevant and insightful questions during Q&A sessions, and be sure to network with speakers after the session if possible. This is a valuable chance to exchange contact information and build relationships with experts in the industry.

Meeting speakers not only gives you an introduction to a leader in the space, it also gives you a foot in the door to their often expansive networks. You may also have the opportunity to collaborate with speakers or seek their guidance following the seminar. By actively engaging with industry experts, you can enhance your professional network, gain valuable mentorship and even open doors to work opportunities. 

4. Network with attendees 

Networking with other attendees is also a great way to make the most out of educational sessions at cannabis trade shows. Engage with other participants and exhibitors by introducing yourself and exchanging contact information – you never know who you might meet or what opportunities may arise from these connections. 

At the show “Where Deals Get Done,” CWCBExpo offers access to breakout rooms where you can sit and chat with any other attendees that you may want to have meetings with, giving you the chance to cement any promising new relationships. Many trade shows also offer post-session gatherings or events for attendees to gather and network in a more casual setting. CWBCExpo promotes a variety of post-show networking events where deal-making and business-building continue beyond the show floor daily experiences and extend into the evening. An example of a well-known industry networking and festive event that CWCBExpo offers is the Industry Yacht Party.

Yacht Party, 2023
Yacht Party, 2023

 

5. Follow up  

Following up after attending an education session is just as important as engaging with the speakers and anyone else you meet. Be sure to review your notes and organize the information you’ve gathered to help reinforce what you’ve learned and identify key takeaways to apply to your business. You can also follow up with speakers and attendees who you exchanged contact information with. Thank them for their time and expertise, and consider arranging a follow-up meeting or call to discuss further collaboration.

Additionally, sharing what you’ve learned with your team or online through social media like LinkedIn can help to build connections and establish yourself as a thought leader in the cannabis space. Set some time the week following a trade show to reach out to your new connections and offer additional time to discuss how you might be able to support one another’s goals.

What educational sessions are at CWCBExpo? 

There are many educational sessions available for attendees of CWCBExpo. The following are examples of the types of educational sessions that were on offer during CWCBExpo 2023:

  • Social Equity: Entrepreneurs, Change Makers, and Heroes 
  • The Future of Cannabis Tourism in the Big Green Apple and Beyond 
  • Compliance Issues for Cannabis Business Owners: Taxation, Liability, and the ERTC Program 
  • The Evolution of Cannabis Marketing from West to East
  • Consumer Products: What are the Most Popular and Hottest Products? 
  • Packaging Cannabis Products Safely & Responsibly 
  • Technology to Maximize ROI for Grow Facilities From Seed to Processing 

Make the most of CWCBExpo 

With extensive educational sessions and a diverse exhibitor line-up, CWCBExpo is the perfect event for cannabis businesses seeking up-to-date insight into the industry. Whether you’re a cannabis business vet or an industry newcomer, the exhibitors and education sessions at CWCBexpo offer a wealth of information and insight on a wide range of topics. If you missed out on CWCBExpo 2023, don’t worry — we’ll be back next year on June 5 – 6, 2024, with a rich lineup of speakers, exhibitors, and attendees dedicated to building the cannabis industry in New York and beyond.

A photograph of Calvin Frye speaking at the podium at CWCBExpo. Calvin is wearing a green shirt and glasses. He is mid-speech.

5 Lessons for Cannabis Entrepreneurs 

The cannabis industry is a hotbed of entrepreneurial activity as new markets open and established ones evolve. Cannabis represents a wealth of opportunities for those who are willing to take risks and innovate, from manufacturers who develop new product types to ancillary services that provide a particular expertise to support flourishing cannabusinesses. 

However, like any industry, there are many pitfalls that entrepreneurs may succumb to, and there are particular challenges in the cannabis industry to be aware of. Much can be learned from other business owners who have experience which could help new cannabis entrepreneurs succeed.

1. Do your research 

As a cannabis entrepreneur, doing your homework is one of the most important steps to take. With the industry still evolving and rapidly changing, it’s critical to stay up-to-date on the latest laws, regulations, and industry trends. Doing your research will not only help you to make informed decisions and avoid costly mistakes but can also give you a competitive edge by helping you identify opportunities in the market. For example, state laws change constantly, and knowing their evolution can help you make savvy, informed decisions about your business.

Resources like the Cannabis World Congress & Business Exposition (CWCBExpo) monthly newsletter, for example, is a great way to stay up-to-date on the latest trends and developments in the industry and connect with other professionals. Other publications, such as Marijuana Moment and Cannabis Business Times, offer valuable insight and information to help you stay informed as well. 

“Find out what has worked and what has not worked and, most importantly, find out what the actual rules are in the state that you wish to operate in because they vary from state to state,” says Calvin Frye, owner of genetics company Cloneville and member of Cannabis World Congress & Business Expo’s advisory board. 

2. Develop a solid business plan 

A roadmap is a must for any entrepreneur in any market, and cannabis is no exception. A business plan serves as your guide forward and is a must for defining your goals, identifying your target market, and developing strategies for financing and growth. The critical elements of a business plan typically include determining your mission statement, conducting market research, developing a marketing strategy, setting goals, and creating financial projections. 

Suppose that you are a cannabis cultivator looking to expand your business. A well-crafted business plan would involve determining your target market and your company’s purpose, values, and finances to ensure that expansion is feasible and sustainable in the long term. It can also serve as an important document to present to potential investors to help you raise the capital you need to launch your business. 

3. Network early and often 

It’s often said that “it’s not what you know, but who you know” that matters in the business world. Building relationships early and often can help you better understand the industry and gain new insights, especially in rapidly-evolving spaces like cannabis. Attending industry events like CWCBExpo, for example, can be a great way to meet other industry professionals and learn from their knowledge and experience. 

When networking, remember to be authentic, genuine, and respectful. Focus less on what you can get out of the relationship and instead look for ways you can add value and help others. And don’t forget to bring your business cards or create a digital card!

Other tips for networking success include asking questions and following up with the people you meet. It never hurts to send a quick email or LinkedIn message after the show to stay in touch and continue building your network. 

4. Build a strong team

Bringing quality talent into your business early is critical for success. With so much competition and so many regulatory hurdles to navigate, you’ll need a team that can help you execute your vision and stay ahead of the curve. When building a team, look for people who not only share your values but bring unique skills and perspectives to the table. For example, if you’re a cannabis retailer, you may want to seek out team members with experience in customer service or marketing. 

Look for people who are passionate about the cannabis industry and be sure to prioritize a positive and inclusive environment. Investing in training and development can also help your team develop and grow and build a culture of continuous learning and improvement. Also consider hiring professional services to support your company. Legal counsel is an absolute must, but financial, marketing, and HR professionals can also augment your team.

5. Embrace innovation 

The cannabis industry is constantly evolving, with new products, technologies, and regulatory changes shaping the landscape daily. As an entrepreneur in this space, finding strategies to stay ahead of the curve is essential. Embracing innovation can help you to differentiate your business from the competition, create new revenue streams, and better serve your customers. 

Think about virtual reality as an example. A cannabis retailer may explore the use of VR to create immersive in-store experiences and better showcase their product offering to customers. Manufacturers may work to refine consumer favorites or develop totally new types of cannabis products. Whether you’re a cultivator, retailer, or anything in between, staying open to new ideas and being willing to take risks will help position your business for long-term success. 

Challenges and opportunities in the cannabis industry 

Cannabis entrepreneurs face a unique set of challenges that can make it complicated to operate in this space. So as you begin your cannabis industry journey, be aware of the following:

  • Legal and regulatory challenges: Cannabis entrepreneurs face a complex and constantly evolving legal landscape, with different laws and regulations governing the plant at federal, state, and local levels. Navigating these challenges is one of the most important priorities for a cannabis entrepreneur.

  • Advertising and marketing restrictions: Cannabis businesses are often subject to strict advertising and marketing regulations, which can limit their ability to reach their target audience and build awareness. These restrictions include traditional and digital advertising limitations, from billboards to social media promotion.

  • Stigma and social acceptance: Despite growing acceptance and legalization of cannabis, there is still a significant amount of stigma associated with the industry. These barriers can limit public support for cannabis businesses and restrict access to certain services.

  • Limited access to traditional business resources: Due to the unique challenges faced by cannabis businesses, entrepreneurs may have limited access to conventional business resources such as banking, loans, networking opportunities, and mentorship programs. 

With great challenges, however, come great opportunities for growth and positive social change. Whether it’s through supporting medical research or advocating for legalization, entrepreneurs navigating the complex landscape of cannabis have the chance to make a difference in the lives of others. So while the challenges are significant, the potential rewards are even greater. 

“It’s never been a more interesting or exciting time for the cannabis industry in the Northeast,” said Kelley Crosson, owner and president of KC Inc. “There is space for everyone in this ever-changing market. ‘Find your focus’ is probably the best advice I can give at the moment.”

Taking the right steps 

Being a successful cannabis entrepreneur requires passion and determination. Luckily, resources like CWCBExpo provide an opportunity to connect with other entrepreneurs, learn about new technologies and products, and stay in the loop on the latest industry trends. Attending our in-person expo and reading our blog can help you to build relationships and stay ahead of the curve in this exciting industry. 

The Packaging Company product display

Industry Deep Dive: Pre-rolls, Papers, and Cones

The pre-roll is one of the most recognizable cannabis products. It’s ubiquitous in many legal cannabis markets, both medical and adult-use. What many people don’t realize, though, is that the rapid growth of this market segment has led to serious innovation. Pre-rolls are no longer the simple 1-gram cones with a filter at the end. You’ll find lots of sizes, infusions, and more.

The types of pre-rolls available, how they are made, and the way they are marketed has evolved significantly since the emergence of the legal cannabis industry. This industry deep dive explores the pre-roll market growth, how the space has changed, and how cannabis businesses can leverage this market.

What does the growth of the Pre-rolls market look like?

Although it’s far from the largest cannabis market segment, pre-rolls represent a significant portion of the U.S. cannabis industry, accounting for 12.7% of market share and generating more than $1.5 billion in sales in 2022. It’s also a fast-growing space, more than tripling in terms of sales revenue since 2018, when the space generated $406 million in sales.

What’s driving that growth, though, may be most interesting. According to Harrison Bard, co-founder of Custom Cones USA, it’s rare that customers stop in just to pick up a few pre-rolls. Instead, they are most commonly added alongside an order as an afterthought or impulse buy.

“Pre-rolls are one of the most attached items,” he said. “[Cannabis] flower is still the most purchased item [in a dispensary] by itself, but pre-rolls have the highest attachment rate. They’re a great add-on item that can increase your customer’s average basket size.”

Leading the way in the space are three California companies Sublime Canna with $33.2 million in sales, Jeeter with $27.2 million, and Lowell Herb Co. with $26.4 million in 2020. The rapid growth of the pre-roll market segment has nearly all brands that produce pre-rolls eyeing expansion in the coming years. According to data from Headset and Custom Cones USA, 95.7% of preroll brands expected to expand following 2020.

The many types of Pre-rolls on the market

As the pre-roll market has grown, the variety of pre-rolls has increased as well. While it’s most common to find 1g pre-rolls in new and developing markets, more mature markets have an entire selection that includes multi-packs of pre-rolls (including two-packs, five-packs, and 10-packs), pre-rolled blunts, 0.5g pre-rolls, and the mini “dog walkers” that range between 0.25g and 0.35g per pre-roll.

Today, 1g pre-rolls remain the most common seller, accounting for 62.6% of the pre-roll center, according to the report from Headset and Custom Cones USA. Close behind are 0.5g pre-rolls at 43.2%, followed by 0.75g pre-rolls at 18.7%, >0.5g pre-rolls at 10.8%, and then >2g pre-rolls at 12.2%.

But it’s not just the size of pre-rolls that’s increasingly varied; it’s the types of pre-rolls available. One type of product, in particular, is becoming a mainstay of the sector.

“We’re seeing infused pre-rolls pick up way more quickly in new markets,” Bard said.

Infused pre-rolls are those that are brushed with extract and, sometimes, rolled in kief, providing an extra potent session. In fact, these types of pre-rolls accounted for 42% of all pre-roll sales in 2022. That’s a marked increase from 2018, when these types of pre-rolls represented just 12.7% of the overall pre-roll market segment, according to the report from Headset and Custom Cones USA.

There are also mixed strain pre-rolls, which include a blend of multiple cultivars (also called strains) designed to accentuate a particular set of effects. Pre-rolled blunts are also rapidly rising in popularity, Bard said.

And each of these product types come in a variety of wraps beyond the conventional refined white paper, such as hemp wraps and flavored wraps. Today, the classic wrap accounts for just 44.3% of the market, followed closely by organic hemp at 35% and unrefined brown wraps at 23.6%, according to the data from Headset and Custom Cones USA. Non-organic hemp is next at 17.1%, followed by natural leaf at 10.7% and cigarette tubes at 8.6%.

It’s also common to find a wider range of quality in more mature markets. A common misconception is that pre-rolls contain mid-shelf cannabis or shake that falls from the buds in transit or during the trimming process, but that’s not always true. While there are certainly lower quality pre-rolls out there, some brands have dedicated themselves to using top shelf flower in their products for consumers who want a more premium experience.

“A lot of companies are emphasizing fresh products. They’re making sure pre-rolls are created to order; they’re not just making 50,000 per month and letting them sit around for ages before going to retail,” Bard said. “I’d liken it to sushi in the grocery store — it’s only good for a few days. After these pre-rolls age too much, they’re processed into an edible or concentrate.”

How dispensaries can make the most out of pre-rolls and paper products

There are a few ways dispensaries can take advantage of pre-rolls (and other paper products like cones) to increase the average transaction size and bolster revenue. Follow these tips to make the most out of pre-rolls and related accessories at your dispensary.

1.    Display pre-rolls prominently at the point of sale

Customers are unlikely to buy what they can’t see, and that includes pre-rolls. Just because they’re not the most sought after product doesn’t mean they shouldn’t be prominently displayed. And, since they’re a common add-on item or impulse purchase like a candy bar at the grocery store checkout aisle, placing them close to the register incentivizes your customers to add them to their basket at the last minute. Notably, not every state allows for this kind of product access on the dispensary floor, so you may need to get creative in states where customers can’t pick up the products themselves.

“Think about how pre-rolls are merchandised in the store,” Bard said. “Some dispensaries keep pre-rolls in buckets beneath the counter, but better merchandising increases sales. Make sure they’re eye-level behind the counter so customers are seeing them at the point of sale.”

2.    Offer pre-rolls as a way to try out something new

Promoting your pre-rolls as a way to try out a different cultivar or brand can prompt customers to consider purchasing additional products. For example, if you’re stocking a new cultivar that you think will be popular, offering high quality pre-rolls that contain that flower could be a good way to get the word out among your customers and drive sales of that flower in the future.

“Pre-rolls are a good way to try out a brand,” Bard said. “It’s like a little sample, an easy way for someone to try new flower or a brand compared to buying an eighth or concentrate. It’s a great way to get more brand exposure by offering a lower price point to consumers that is more accessible.”

3.    Keep a variety of pre-rolls in stock

As the pre-roll market evolves, there are more types of pre-rolls available. Don’t just stock the typical 1g pre-rolls; your customers are likely to expect pre-rolled blunts, multi-packs, and infused pre-rolls as well. Ensuring you have a diversified inventory of pre-roll products increases the odds that your customers will find the type of pre-roll they prefer.

“You definitely want to offer multi-packs and infused pre-rolls,” Bard said. “I would say flavors are important too. Variety is really important for a dispensary, so offer different flavors and strains.”

4.    Include pre-rolls in product bundles to boost sales

If you want to encourage customers to purchase larger baskets, consider offering pre-rolls in a product bundle at a favorable price. Your customers will feel like they’re getting a price break on product, and you’ll use pre-rolls to drive larger transaction sizes. This can help boost revenue per customer and move more product, especially when you’re looking to bring in new inventory.

5.    Sell rolling papers and cones for customers who roll their own

There are some consumers who prefer to work with flower they’ve purchased in bulk, as well as some who avoid pre-rolls due to a misconception that they are necessarily lower quality products. When it comes to these consumers, it’s good to keep rolling papers and empty cones on hand.

“Flower remains the number one selling category, so for people who don’t know how to roll, cones are really popular, and papers are popular with those who know how to roll,” Bard said. “Also, pre-rolls have this negative stigma that they’re low quality, so some people won’t buy them even though there are high-quality pre-rolls on the shelves. It’s still good to have empty cones for those customers.”

Automation and the cannabis pre-roll market

In the early days of the cannabis industry, it was common for dispensary employees to spend a portion of their day manually producing pre-rolls to sell throughout the dispensary. Now, that’s far less common, as automated rolling machines — some that are quite sophisticated — have become the norm. Automated pre-roll machinery is capable of producing thousands of pre-rolls per hour while freeing up dispensary staff to attend to more pressing tasks.

Paxiom by Canapa Solutions is one such pre-roll automation company that has pioneered this space with units like its JuanaRoll 8-channel, which is capable of turning out 4,000 pre-rolls per hour, according to digital marketing specialist and project manager Val Miller.

“All companies typically begin with hand packaging or semi-automatic volumetric systems,” Miller said. “As companies grow, it becomes very difficult to scale without automation to produce high productivity and consistency.”

Automation at this scale is most likely to be used by manufacturers who are creating high volumes of products to ship to retail locations throughout their state, rather than the dispensaries themselves. They can significantly cut down the time and costs required to produce enough pre-rolls to fill multi-packs at scale, for example. The volume needed to meet that demand can be quite immense, depending on how many dispensaries a manufacturer is selling to.

To improve scalability and meet growing demand, Miller said Paxiom developed the JuanaRoll as a modular solution that could begin as a one channel machine and expand as a company needs up to a maximum of eight channels. There are fully automated and semi-automated models available.

But just because pre-roll production is trending increasingly toward automation doesn’t mean the human element is entirely eliminated, though. Success still requires coordination between manufacturers and the automated equipment vendor.

“Filling and packaging pre-rolls is very difficult and requires a team effort between us, the manufacturer, the cone supplier, our customers and the dedicated people that operate them,” Miller said. “It’s important to work within a cohesive group that have the same goals and can collaborate.”

Pre-rolls are a growing wave of the future

The pre-roll space doesn’t often get as much press as whole flower or concentrated extracts, but it’s just as unique and lively. As pre-roll sales grow well beyond the $1 billion mark, the space has continued to evolve along with the rest of the cannabis industry. Clearly a mainstay for any manufacturer or retailer in cannabis today, pre-rolls are an important hallmark of the industry and will continue to be central to the space for years to come. Whether you’re serving consumers or manufacturing to meet the needs of dispensaries, understanding this growing market and how to best compete can be an important recipe for success.

Cannabis leaves and dollars

Industry Deep Dive: Cannabis and Investing

Investing in the cannabis industry is not the same as investing in mainstream industries. Navigating where to put one’s money in any start-up, stock, or established company is challenging. Cannabis concerns are especially challenging in a federally illegal designation. However, 36 states have either medical and/or adult use laws that make investing in cannabis attractive to entrepreneurs, investors, and ancillary businesses.  The upside and future for the cannabis industry is what is attractive for investors. 

This deep dive takes a look at cannabis investing, the challenges surrounding it, and some of the ways cannabis businesses are securing the capital funding they need to grow despite these obstacles.

What is the investment landscape in cannabis?

Unlike other industries, such as the tech sector, investing in cannabis is not usually as simple as buying and selling stocks on a stock exchange like NYSE or NASDAQ. While there are some big companies that have been publicly traded in this way, the majority of the cannabis industry cannot access this space in the U.S.

However, that doesn’t mean investors can’t get involved in the industry in other ways. Whether relying on private investment firms or alternative methods of indirectly investing in the growth of cannabis, there’s no shortage of opportunities to get involved in the space.

“There are lots of ways people can invest in cannabis,” said Sumit Mehta, CEO of investment firm Mazakali. “Cannabis is a market I would think about in five categories: plant-touching businesses from retail to cultivation, non-plant-touching ancillary businesses, hemp and CBD, real estate, and international markets.”

Internationally, Canada is the only country to have a fully legalized stock market for public cannabis businesses, said Mehta, who is also a strategy and finance consultant for the Arcview Group. However, he added, people who want to invest in the domestic market can still do so despite the lack of a robust public market.

“You can’t get a stock price every day and trade out, [but you can] go directly into private companies all over the country,” Mehta said. “The other way is to invest in real estate funds, which are a sound investment because they can be repurposed and are enjoying high rents from cannabis tenants.”

Challenges facing cannabis investors

While cannabis is predicted to grow immensely as an industry — eclipsing $40 billion by 2030 according to Grandview Research — there are some challenges that investors should be aware of. Cannabis is an industry that faces a lot of restrictions, so despite the estimated growth projections, investors should be aware that there is no such thing as a sure bet, especially in cannabis.

IRS Section 280E

One of the biggest obstacles to profitability for cannabis companies is IRS Section 280E, a tax code which disallows state-legal cannabis businesses from taking federal tax deductions that businesses in other industries claim all the time. Instead, cannabis businesses are only allowed to deduct the cost of goods sold (COGS) from their federal tax liability. 

“Very simply, 280E means the difference between revenue and profitability is greater for cannabis businesses than those in any other industry in the U.S.,” Mehta said.

The result is that many high-revenue cannabis businesses have much thinner margins than they would otherwise, which means a lower rate of return for investors. The code may even impact a business’s ability to turn a profit altogether, even if the business model and fundamentals seem sound.

Banking restrictions

Cannabis businesses face limited access to the U.S. banking system, meaning many have to deal with cash and are unable to process debit and credit card transactions. Those who do have bank accounts and merchant processing accounts are susceptible to sudden closures leaving them without a banking solution, in some cases overnight. In addition to these business disruptions, cannabis businesses often don’t have access to conventional bank loans and lines of credit. When this is the case, the lack of capital can restrict the growth of a business and delay the return on investment to a company’s investors.

Lack of interstate commerce

The state-by-state legalization of medical and adult-use cannabis has led to isolated state markets that need their own supply chains. The lack of interstate commerce has not only slowed the growth potential of the industry as a whole, but has led to a proliferation in the total number of cannabis businesses operating in these fragmented markets, making it difficult for investors to identify the future winners.

“Because cannabis is federally illegal, you cannot transport it across state lines,” Mehta said. “The industry is massively different from others in that you have seed to sale supply chains within state lines, and if or when the federal government drops Prohibition, it will be a massive change for the industry.”

The result, Mehta said, is that there are 80,000 licensed businesses in cannabis throughout legal states and 160,000 more unlicensed businesses competing for the same market share without the same restrictions. 

Will federal legalization resolve cannabis investing challenges?

Federal legalization would likely get the ball rolling on the changes Mehta predicts for the industry, but he doesn’t anticipate it happening quickly. Instead, over the course of years, Mehta expects a gradual rollout of a regulatory framework and the subsequent slow adaptation by the industry based on those rules.

“I would expect that even if the federal government takes action, it would take north of five years for the government to adopt their own regulations to even begin controlling the industry,” Mehta said. “Hopefully, in the meantime, the IRS effectively takes away 280E to allow companies with healthy revenue to show a healthy profit.”

“The second thing that would happen is, hopefully, these state border walls will fall,” he added. “We grow spinach in California and ship it to Arizona, so why don’t we do that with cannabis? But the states will fight this tooth and nail; they now have industries, jobs, and tax revenue that would leave the state.”

While optimism around the prospect of federal legalization fixing cannabis challenges may be mixed, that doesn’t mean the industry isn’t still rife with opportunity. However, it does mean that the capital flowing into new businesses is not as readily available as it once was. 

“There was a lot of euphoria for legalization and the expectation that banking and tax issues would be lifted,” he said.

Funding options for cannabis businesses

Despite reticence on the part of many investors due to the restrictions surrounding the cannabis industry, there are still several options for entrepreneurs when it comes to funding their ventures. These are the most common ways businesses are funded in cannabis:

  • Bootstrapping: In many cases, founders use their personal funds to start their cannabis business and get it off the ground. Of course, bootstrapping a company comes with certain limitations that could restrict the growth of the business. However, it’s a good option to get the foundation in place and begin generating some revenue to prove the viability of your business model.
  • Friends and family: With limited conventional lending options, many new cannabis businesses seek investment or loans from friends and family. While this may be ideal for new businesses or those that only need to hire an employee or two, an informal friends and family capital raise might not be suitable for businesses that are trying to scale up significantly.
  • Line of credit or business credit cards: Some banks are willing to work with cannabis businesses, although it can be a challenge to find them. If you do, though, you may qualify for a line of credit or business credit card that can be used to help grow your business. Unlike a bank loan, you’ll only pay for the credit you use. However, be sure to check the terms and interest rates of any line of credit or credit card you accept, as these sometimes include restrictive requirements.
  • Private investors: Most cannabis businesses won’t go public even when the public markets are unrestricted to the industry. Instead, those that court investors will likely do so through one of three avenues: Reg CF, Reg A+, or Reg D capital raises. Reg CF enables equity crowdfunding, allowing many accredited investors to purchase a small stake in a private company, which could be useful for smaller, growing companies that need to raise capital to expand. Reg A+ and Reg D allow for private placements to investors for larger scale capital raises.

Exploring opportunities for investors in cannabis

With the right guidance and know-how, investors can identify and fund lucrative opportunities within the cannabis industry. One way to do so is at the CannaVest East Institutional Capital Forum, held alongside CWCBExpo at the 2023 conference. This forum has been created specifically with the needs of the family office and sophisticated accredited investor in mind. Qualified attendees will get an in-depth look into the opportunistic cannabis industry and explore a broad range of investment opportunities. Visit the CWCBExpo website to see qualifications and learn more about this year’s conference, held June 1-3, 2023 at the Jacob K. Javits Convention Center in New York City. 

Speaker Applications are

Loading...